Table 1.
Clinical characteristics of study participants with type 2 diabetes
| Variables | |
|---|---|
| Age (years) | 59.9 ± 13.2 |
| Sex (male/female) | 26/28 |
| Body mass index (kg/m2) | 27.9 ± 5.5 |
| Duration of diabetes (years) | 5.9 ± 6.7 |
| Diabetes complications | |
| Neuropathy, n (%) | 23 (42.6) |
| Retinopathy, n (%) | 12 (22.2) |
| Nephropathy, n (%) | 16 (29.6) |
| Fasting glucose (mg/dL) | 153.9 ± 39.7 |
| HbA1c (%) | 8.9 ± 1.8 |
| eGFR (mL/min/1.73 m2) | 88.4 ± 42.1 |
| Diabetes therapy at discharge | |
| Diet only, n (%) | 0 (0) |
| Oral agents only, n (%) | 42 (77.8) |
| GLP‐1 RA only, n (%) | 1 (1.9) |
| Insulin only, n (%) | 0 (0) |
| Oral agents + GLP‐1 RA, n (%) | 7 (13.0) |
| Oral agents + insulin, n (%) | 3 (5.6) |
| GLP‐1 RA + insulin, n (%) | 1 (1.9) |
Data are mean ± SD or n (%); n = 54. eGFR, estimated glomerular filtration rate; GLP‐1 RA, glucose‐like peptide 1 receptor agonist; HbA1c, hemoglobin A1c.